MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT04981509 | RECRUITING | PHASE2
65 participants

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2022-06-10
Completion:
2027-12-31
Conditions
  • Hereditary Leiomyomatosis and Renal Cell Carcinoma
  • Papillary Renal Cell Carcinoma
  • Renal Cell Carcinoma
  • Sporadic Papillary Renal Cell Carcinoma
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
No Results Yet
NCT04934722 | COMPLETED | PHASE3
186 participants

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2021-05-25
Completion:
2022-10-31
Conditions
  • Metastatic Hormone-Sensitive Prostate Cancer
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
Results Available
NCT04930653 | RECRUITING | PHASE2
34 participants

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2022-10-19
Completion:
2028-06-15
Conditions
  • Folliculotropic Mycosis Fungoides
  • Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Sezary Syndrome
  • Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Transformed Mycosis Fungoides
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT04902508 | ACTIVE_NOT_RECRUITING | NA
111 participants

Evaluation of an Explicit Approach

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2022-02-15
Completion:
2027-07-31
Conditions
  • Developmental Language Disorder
  • Explicit Intervention
  • Grammatical Language
Interventions
  • BEHAVIORAL
No Results Yet
NCT04803201 | RECRUITING | PHASE2
170 participants

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2021-10-08
Completion:
2027-05-19
Conditions
  • Angioimmunoblastic T-cell Lymphoma
  • Enteropathy-Associated T-Cell Lymphoma
  • Follicular T-Cell Lymphoma
  • Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
  • Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
Interventions
  • DRUG
No Results Yet
NCT04534205 | RECRUITING | PHASE2/PHASE3
350 participants

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2021-01-07
Completion:
2028-08-31
Conditions
  • Unresectable Head and Neck Squamous Cell Carcinoma
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
Interventions
  • BIOLOGICAL
No Results Yet
NCT04462978 | RECRUITING
150 participants

Non-Immunoglobulin E-mediated Food Allergies in Children

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-02
Start Date:
2017-01-01
Completion:
2023-12-30
Conditions
  • Non IgE Mediated Food Allergy
  • Food Protein-Induced Enteropathy
  • Food Protein-Induced Proctocolitis
  • Food Protein-Induced Enterocolitis Syndrome
  • Food Protein-induced Motility Disorders
Interventions
  • OTHER
No Results Yet
NCT04426786 | ACTIVE_NOT_RECRUITING | NA
40 participants

Exercise & Brain Energetics in PD

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2021-01-26
Completion:
2026-12-30
Conditions
  • Parkinson Disease
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page